Similarly, clonogenic survival was significantly reduced by mTOR blockade specifically in the H7 MVP-positive background (Figure 4E, lower panel) and all endogenously MVP-expressing GBM cell models tested (RAEW representatively in Supplementary Figure S3). The gene discussed is MTOR; the disease is glioblastoma.